Halo and LaseMD Ultra sit in the same skin resurfacing category but take different approaches. Halo (Sciton) uses Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass) while LaseMD Ultra (Lutronic) uses 1927nm Thulium Non-Ablative Fractional Laser. Both received FDA clearance (2015 and 2021 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $145,000-$210,000 (as Joule module) to $60,000-$95,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
Side-by-Side Specifications
Halo
LaseMD Ultra
Manufacturer
Sciton
Lutronic
Technology
Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass)
1927nm Thulium Non-Ablative Fractional Laser
Price (New)
$145,000-$210,000 (as Joule module)
$60,000-$95,000
Price (Used)
$80,000-$140,000
$25,000-$50,000
Treatment Time
30-45 minutes
15-30 minutes
Sessions
1-3 sessions spaced 4-6 weeks apart
3-5 sessions spaced 2-4 weeks apart
Per Session
$1,200-$2,500
$500-$1,200
Annual Consumables
$2,000-$5,000
$1,000-$3,000
Annual Maintenance
$5,000-$10,000
$3,000-$6,000
FDA Cleared
Yes (2015)
Yes (2021)
Technology
Halo
Technology: Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass). First and only hybrid fractional laser that delivers ablative and non-ablative wavelengths in a single pass. Dynamic Thermal Optimization adjusts energy in real-time to maintain target temperature.
LaseMD Ultra
Technology: 1927nm Thulium Non-Ablative Fractional Laser. Thulium wavelength targets superficial pigmentation, tone, and texture with minimal downtime. Integrated ampoule delivery allows topical cosmeceutical infusion through the laser channels immediately after treatment.
Strong peer-reviewed base. Multiple blinded-evaluator studies showing significant improvement in photodamage, fine lines, and skin tone.
LaseMD Ultra
15+ peer-reviewed studies. Growing base since 2021 launch of the Ultra version.
Treatment Experience
Halo
30-45 minutes per session. Recommended protocol: 1-3 sessions spaced 4-6 weeks apart. Treatment areas: Face, Neck, Decolletage, Hands, Arms. Patients typically tolerate this platform well when operated by trained clinicians.
LaseMD Ultra
15-30 minutes per session. Recommended protocol: 3-5 sessions spaced 2-4 weeks apart. Treatment areas: Face, Neck, Decolletage, Hands. Patient experience varies by operator training and settings.
Practice Fit
Halo
High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Joule ecosystem.
LaseMD Ultra
Med spas and dermatology practices that want a low-downtime resurfacing option at a reasonable capital cost. Practices that can package ampoule add-ons into per-session revenue.
Pros and Cons
Halo Pros
Hybrid ablative plus non-ablative design in one pass
Dynamic Thermal Optimization keeps results consistent across passes
Built on the Sciton Joule platform alongside BBL and MOXI modules
Strong premium positioning supports high per-session pricing
Halo Cons
Joule platform pricing runs well above category competitors
Requires 3-5 days of social downtime (sandpaper texture)
Operator training is involved and takes weeks to master
LaseMD Ultra Pros
Minimal downtime (1-3 days) supports high patient conversion
Topical ampoule delivery creates an add-on revenue line
Lower capital and per-session cost than Halo or Fraxel
Quick 15-30 minute protocols fit busy practice schedules
LaseMD Ultra Cons
Less dramatic single-session results than ablative fractional lasers
Newer platform with thinner peer-reviewed evidence base
Lutronic ownership uncertainty limits long-term service visibility
The Verdict
Choose Halo if your practice prioritizes Sciton's ecosystem, brand recognition, or specific clinical advantages. High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Joule ecosystem. The pros that matter most: Hybrid ablative plus non-ablative design in one pass; Dynamic Thermal Optimization keeps results consistent across passes. The biggest tradeoff to accept: Joule platform pricing runs well above category competitors.
Choose LaseMD Ultra if Lutronic's positioning fits better. Med spas and dermatology practices that want a low-downtime resurfacing option at a reasonable capital cost. Practices that can package ampoule add-ons into per-session revenue. The pros that matter most: Minimal downtime (1-3 days) supports high patient conversion; Topical ampoule delivery creates an add-on revenue line. The biggest tradeoff to accept: Less dramatic single-session results than ablative fractional lasers.
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Halo used units run $80,000-$140,000; LaseMD Ultra used units run $25,000-$50,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
Frequently Asked Questions
Which is more expensive, Halo or LaseMD Ultra?
Halo runs $145,000-$210,000 (as Joule module) new and $80,000-$140,000 used. LaseMD Ultra runs $60,000-$95,000 new and $25,000-$50,000 used. Per-session pricing is $1,200-$2,500 for Halo and $500-$1,200 for LaseMD Ultra. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Halo or LaseMD Ultra?
Halo clinical evidence: Strong peer-reviewed base. Multiple blinded-evaluator studies showing significant improvement in photodamage, fine lines, and skin tone. LaseMD Ultra clinical evidence: 15+ peer-reviewed studies. Growing base since 2021 launch of the Ultra version. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Halo or LaseMD Ultra more popular in dermatology practices?
Both Halo and LaseMD Ultra are commonly used in dermatology, plastic surgery practices. Market share in any given category shifts year to year. Sciton and Lutronic both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Halo or LaseMD Ultra?
Both devices are FDA cleared and have established safety profiles. Halo has these documented concerns: Joule platform pricing runs well above category competitors. LaseMD Ultra has: Less dramatic single-session results than ablative fractional lasers. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Halo and LaseMD Ultra in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Halo and LaseMD Ultra?
Used Halo sells for $80,000-$140,000 on the secondary market. Used LaseMD Ultra sells for $25,000-$50,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.
Halo vs LaseMD Ultra: which is better for dermatology practices in 2026?
For dermatology practices specifically in 2026, the choice between Halo and LaseMD Ultra depends on three factors: existing equipment compatibility (does the new device integrate with what you already run), patient mix and treatment volume (high-volume practices typically benefit from Halo's hybrid ablative plus non-ablative design in one pass while lower-volume practices often prefer LaseMD Ultra's minimal downtime (1-3 days) supports high patient conversion), and total cost of ownership over 5 years including consumables and maintenance. Run the side-by-side TCO analysis with realistic patient volume projections before committing to either platform.
Halo vs LaseMD Ultra: 2026 update on features and clinical evidence?
As of April 2026, both Halo and LaseMD Ultra continue commercial availability from Sciton and Lutronic respectively. Recent updates worth tracking: software releases, new applicator launches, expanded FDA labeling indications, and new peer-reviewed clinical evidence publications. Manufacturer financial stability also matters for long-term support and parts availability. Both manufacturers share business updates periodically that inform the long-term outlook for each device.
How do I choose between Halo and LaseMD Ultra for my practice?
Use a structured decision framework: list 5-7 must-have requirements specific to your patient mix and practice economics, score Halo and LaseMD Ultra against each requirement on a 1-5 scale, weight the requirements by importance, then sum the weighted scores. The platform that scores meaningfully higher (10%+ gap) is the right choice. If the scores are within 10%, secondary factors decide: manufacturer relationship, financing terms, training availability, and resale value. Avoid choosing based on feature breadth alone because most devices in this category have similar feature checkboxes. The differentiation is in workflow fit, treatment results, and total cost over 5 years.
Are there better alternatives to Halo or LaseMD Ultra in the skin resurfacing category?
In the skin resurfacing category, Halo and LaseMD Ultra are often the leading platforms but other alternatives may fit specific practice profiles better. Other category options include ultrapulse, fraxel-dual, clear-brilliant. Run a 4-platform shortlist evaluation rather than a 2-platform binary because hidden alternatives sometimes outperform on the metrics that matter most to your specific practice.